Formaldehyde allergies are increasingly raising health concerns. Delve into symptoms, risks, and management options to ...
A new analysis of US Maternal Mortality Review Committee data found that 86% of pregnancy-related deaths from infection were ...
FSSAI has proposed prominent red warnings on packaged foods high in sugar, salt or saturated fat, but research suggests ...
WHO's renewed Science Council aims to transform health research and policy. Uncover the council's vision for a healthier ...
A resurfaced case report describes how a man's attempt to stop urine leakage with superglue caused a blockage requiring ...
FSSAI has prohibited the sale of specified Everest and Laljee Godhoo hing products after samples failed quality and labelling ...
FDA has approved Lumisight (pegulicianine), a fluorescent imaging drug that helps surgeons spot cancer tissue left behind in ...
This evaluation in a complex patient further supports OMEZA's published data showing high efficacy and patient satisfaction when treating refractory wounds. Cynthia Flowers CEO ...
Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that it has submitted a supplemental New Drug Application ...
Women are more likely to get migraines than men, but hormones are only part of the story. Learn how periods, estrogen and ...
IDEAYA Biosciences Announces Successful FDA Type C Meeting for IDE849, DLL3 TOP1 ADC, on Phase 3 Registrational Trial Design for Potential Accelerated and Full Approval in Extensive Stage Small Cell ...
Eli Lilly and Company (NYSE: LLY) and Merida Biosciences, Inc. (Merida), a biotechnology company advancing a new class of precision therapeutics for serious autoimmune and allergic diseases, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results